About Astrazeneca Pharma India Ltd
Astrazeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company.
Founded
1979
CEO
Shilpa Divekar Nirula
Employees
760
HQ
Bangalore, India
Finished Products
1Sale of Products
₹3,755.82Cr2Service Income
₹255.97Cr3Income from grant
₹3.00CrRaw Materials
1Purchases of Traded Goods
₹3,899.89Cr2Raw Material Consumed
₹578.44Cr3Packg.Mtls.
₹21.19CrAbout Astrazeneca Pharma India Ltd
Astrazeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company.
Founded:1979
CEO:Shilpa Divekar Nirula
Employees:760
HQ:Bangalore, India
Finished Products
1Sale of Products
₹3,755.82Cr2Service Income
₹255.97Cr3Income from grant
₹3.00CrRaw Materials
1Purchases of Traded Goods
₹3,899.89Cr2Raw Material Consumed
₹578.44Cr3Packg.Mtls.
₹21.19CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹9,850
52W Low
₹6,835
Volume4.79K
Avg VolumeN/A
Beta0.53
Dividend Yield0.52%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
101.26x
Valuation
P/B Ratio
19.68x
Valuation
EPS
₹67.85
Valuation
Dividend Yield
0.52%
Valuation
ROE
21.49%
Profitability
ROCE
25.53%
Profitability
Revenue by Segment
Contribution & growth by business line
Injectables
+55.2%49.1%
₹1,059.52 Cr
Tablets
+16.4%48.5%
₹1,045.73 Cr
Inhalation
+34.8%1.7%
₹36.73 Cr
Powder
N/A0.6%
₹13.9 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
94.8%
International
5.2%
India94.8%
Outside India5.2%
Strategic Relations
Collaborations, joint ventures & subsidiaries
A
Astra Pharmaceuticals AB
Sweden
51.50% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.13x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
20.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.